VERÓNICA
RODRÍGUEZ ALONSO
Profesora asociada
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (7)
2010
-
Comparative in vitro effects of soybean isoflavones and resveratrol on human osteoblastic cells
Isoflavones: Biosynthesis, Occurrence and Health Effects (Nova Science Publishers, Inc.), pp. 181-194
2009
-
Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells
Life Sciences, Vol. 85, Núm. 11-12, pp. 421-430
2008
-
Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2
Journal of Cellular Physiology, Vol. 217, Núm. 3, pp. 717-727
-
Receptor activator of nuclear factor-κB ligand (RANKL) as a novel prognostic marker in prostate carcinoma
Histology and Histopathology, Vol. 23, Núm. 6, pp. 709-715
2007
-
Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: Relative chanqes or parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand
Journal of Clinical Pathology, Vol. 60, Núm. 3, pp. 290-294
2006
-
Diferentes dosis de los fitoestrógenos genisteína y daidzeína afectan de distinto modo a la viabilidad celular y a la expresión de factores implicados en el desarrollo del cáncer de próstata
Revista Espanola de Enfermedades Metabolicas Oseas, Vol. 15, Núm. 5, pp. 91-97
-
Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro
Calcified Tissue International, Vol. 79, Núm. 5, pp. 360-369